PROC
Vitamin K-dependent protein C
Also known as: PROC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04070
- Gene
- PROC
- Ensembl
- ENSG00000115718
- Chromosome
- 2
- Canonical length
- 461 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a vitamin K-dependent plasma glycoprotein. The encoded protein is cleaved to its activated form by the thrombin-thrombomodulin complex. This activated form contains a serine protease domain and functions in degradation of the activated forms of coagulation factors V and VIII. Mutations in this gene have been associated with thrombophilia due to protein C deficiency, neonatal purpura fulminans, and recurrent venous thrombosis.[provided by RefSeq, Dec 2009]
Canonical amino-acid sequenceUniProt
461 residues, UniProt reviewed canonical sequence.
>P04070|PROC
1 MWQLTSLLLF VATWGISGTP APLDSVFSSS ERAHQVLRIR KRANSFLEEL RHSSLERECI
61 EEICDFEEAK EIFQNVDDTL AFWSKHVDGD QCLVLPLEHP CASLCCGHGT CIDGIGSFSC
121 DCRSGWEGRF CQREVSFLNC SLDNGGCTHY CLEEVGWRRC SCAPGYKLGD DLLQCHPAVK
181 FPCGRPWKRM EKKRSHLKRD TEDQEDQVDP RLIDGKMTRR GDSPWQVVLL DSKKKLACGA
241 VLIHPSWVLT AAHCMDESKK LLVRLGEYDL RRWEKWELDL DIKEVFVHPN YSKSTTDNDI
301 ALLHLAQPAT LSQTIVPICL PDSGLAEREL NQAGQETLVT GWGYHSSREK EAKRNRTFVL
361 NFIKIPVVPH NECSEVMSNM VSENMLCAGI LGDRQDACEG DSGGPMVASF HGTWFLVGLV
421 SWGEGCGLLH NYGVYTKVSR YLDWIHGHIR DKEAPQKSWA PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PROC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 584 nTPM
Expression across tissuesHPA
Tissue
- liver: 584 nTPM
- kidney: 14 nTPM
- stomach: 2.5 nTPM
- hypothalamus: 1.5 nTPM
- amygdala: 1.4 nTPM
- hippocampal formation: 1.4 nTPM
Single-cell type
- hepatocytes: 520 nCPM
- cholangiocytes: 54 nCPM
- pdcs: 51 nCPM
- proximal tubule cells: 26 nCPM
- tuft cells: 23 nCPM
- goblet cells: 20 nCPM
Immune cell
- plasmacytoid DC: 60 nTPM
- neutrophil: 6.3 nTPM
- memory B-cell: 1.2 nTPM
- myeloid DC: 0.3 nTPM
- total PBMC: 0.3 nTPM
- naive B-cell: 0.1 nTPM
Brain region
- medulla oblongata: 4.6 nTPM
- pons: 4.4 nTPM
- cerebral cortex: 3.5 nTPM
- hypothalamus: 3.5 nTPM
- white matter: 3.3 nTPM
- thalamus: 3.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PROC.
Disease | AllUniProt
Conditions PROC is implicated in, by any mechanism.
- Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) MIM:176860
- Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) MIM:612304
Disease | GeneticClinVar
111 pathogenic / likely-pathogenic of 480 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Thrombophilia due to protein C deficiency, autosomal dominant
- Thrombophilia due to protein C deficiency, autosomal recessive
- Reduced protein C activity
- PROC-related disorder
- Hereditary thrombophilia due to congenital protein C deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood coagulation
- negative regulation of apoptotic process
- negative regulation of blood coagulation
- negative regulation of coagulation
- negative regulation of inflammatory response
- positive regulation of establishment of endothelial barrier
- proteolysis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-type aspartate/asparagine hydroxylation site
- Gamma-carboxyglutamic acid-rich (GLA) domain
- EGF-like domain
- Serine proteases, trypsin domain
- Peptidase S1A, chymotrypsin family
- EGF-like calcium-binding domain
- Peptidase S1, PA clan
- Peptidase S1A, coagulation factor VII/IX/X/C/Z
- Coagulation factor-like, Gla domain superfamily
- EGF-like calcium-binding, conserved site
- Serine proteases, trypsin family, histidine active site
- Serine proteases, trypsin family, serine active site
- Gamma-carboxyglutamic acid-rich (GLA) domain superfamily
- Peptidase S1 family, coagulation factors
- Trypsin
- Vitamin K-dependent carboxylation/gamma-carboxyglutamic (GLA) domain
- Coagulation Factor Xa inhibitory site
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PROC as an antibody target. Whether an autoantibody or antibody against PROC could matter depends on whether native PROC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PROC is annotated as secreted, so native PROC circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PROC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...